1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Angina Pectoris in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (36.36) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, KH; Kim, JR; Park, J; Shin, DG | 1 |
| Egresits, J; Kordás, K; László, F; László, FA; Morschl, E; Nemcsik, J; Pávó, I | 1 |
| Bannon, PG; Cartland, S; Geczy, C; Kritharides, L; Orr, Y; Taylor, JM | 1 |
| Davies, BH; Gray, M; Hughes, KT; Jones, KP; Reynolds, SP; Rolf, S | 1 |
| Elisaf, M; Goudevenos, J; Michalis, L; Ninio, E; Sideris, DA; Tselepis, AD; Tsoukatos, DC; Vini, MP | 1 |
| Ankri, A; Drobinski, G; Grosgogeat, Y; Maclouf, J; Mencia-Huerta, JM; Montalescot, G; Thomas, D | 1 |
| Gereliuk, IP; Stukal, IV | 1 |
| Kendrew, PJ; Nidorf, SM; Strophair, J; Sturm, M; Taylor, RR | 1 |
| Bugriĭ, EM; Karpov, IuA; Kiktev, VG; Kuz'min, AV; Men'shikov, MIu | 1 |
| Hansen, BF; Hansen, JF | 1 |
| Gratsianskiĭ, NA; Men'shikov, MIu; Panchenko, EP; Shalaev, SV; Tkachuk, VA | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Angina Pectoris
| Article | Year |
|---|---|
[Unstable angina pectoris, acute myocardial infarct, sudden heart death. Patho-anatomy and pathophysiology].
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Calcium Channel Blockers; Coronary Angiography; Coronary Vessels; Death, Sudden; Endoscopy; Heparin; Humans; Myocardial Infarction; Platelet Activating Factor | 1987 |
10 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Angina Pectoris
| Article | Year |
|---|---|
Females with angina pectoris have altered lipoprotein metabolism with elevated cholesteryl ester transfer protein activity and impaired high-density lipoproteins-associated antioxidant enzymes.
Topics: Angina Pectoris; Antioxidants; Apolipoprotein C-III; Aryldialkylphosphatase; Biomarkers; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Female; Humans; Hypertriglyceridemia; Lecithins; Lipoproteins, HDL; Lipoproteins, LDL; Platelet Activating Factor; Triglycerides | 2012 |
Synergistic interaction of endogenous platelet-activating factor and vasopressin in generating angina in rats.
Topics: Angina Pectoris; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Diterpenes; Dose-Response Relationship, Drug; Drug Interactions; Electrocardiography; Epinephrine; Ginkgolides; Heart Rate; Hormone Antagonists; Injections, Intravenous; Lactones; Male; Myocardial Ischemia; Ornipressin; Phentolamine; Platelet Activating Factor; Rats; Rats, Wistar; Receptors, Vasopressin; Time Factors; Vasoconstrictor Agents; Vasopressins | 2004 |
Conformational activation of CD11b without shedding of L-selectin on circulating human neutrophils.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; CD11b Antigen; Chronic Disease; Complement C3a; Coronary Artery Bypass; Epitopes; Female; Flow Cytometry; Heparin; Humans; Interleukin-8; L-Selectin; Macrophage-1 Antigen; Male; Middle Aged; Neutrophil Activation; Neutrophils; Platelet Activating Factor; Prospective Studies; Protein Conformation; Signal Transduction | 2007 |
Salivary PAF in acute myocardial infarction and angina: changes during hospital treatment and relationship to cardiac enzymes.
Topics: Angina Pectoris; Asthma; Creatine Kinase; Enzyme-Linked Immunosorbent Assay; Fibrinolytic Agents; Humans; Myocardial Infarction; Platelet Activating Factor; Radioimmunoassay; Receptors, Interleukin-2; Saliva; Tuberculosis, Pulmonary | 1994 |
Platelet-associated and secreted PAF-acetylhydrolase activity in patients with stable angina: sequential changes of the enzyme activity after angioplasty.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Blood Platelets; Female; Hemostatics; Humans; In Vitro Techniques; Male; Middle Aged; Phospholipases A; Platelet Activating Factor; Platelet Aggregation; Thrombin | 2001 |
Lack of platelet-activating factor release during reversible myocardial ischaemia.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Humans; Myocardial Ischemia; Platelet Activating Factor; Thromboxane B2 | 1992 |
[Disorders of plasma lipid spectrum, lysoform levels of platelet activating factor and blood platelet sensitivity to adrenaline in patients with stable stress-induced stenocardia].
Topics: Adult; Angina Pectoris; Blood Platelets; Epinephrine; Humans; Hypercholesterolemia; In Vitro Techniques; Lipids; Lysophosphatidylcholines; Male; Middle Aged; Platelet Activating Factor; Psychophysiologic Disorders; Stress, Psychological | 1991 |
Whole blood aggregation, thromboxane release and the lyso derivative of platelet activating factor in myocardial infarction and unstable angina.
Topics: Adenosine Diphosphate; Aged; Angina Pectoris; Angina, Unstable; Collagen; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activating Factor; Platelet Aggregation; Thromboxane B2 | 1989 |
[Calcium metabolism of the thrombocytes in ischemic heart disease].
Topics: Adenosine Diphosphate; Adult; Aged; Angina Pectoris; Blood Platelets; Calcium; Coronary Disease; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activating Factor; Platelet Aggregation; Time Factors | 1988 |
[Free cytoplasmic calcium and thrombocyte aggregation in patients with ischemic heart disease. The effect of ADP, thrombocyte activation factor and serotonin].
Topics: Adenosine Diphosphate; Adult; Angina Pectoris; Blood Platelets; Calcium; Coronary Artery Disease; Coronary Disease; Cytoplasm; Humans; Male; Middle Aged; Myocardial Infarction; Physical Exertion; Platelet Activating Factor; Platelet Aggregation; Serotonin | 1986 |